DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • Outset Medical’s Leslie Trigg explains how home-based dialysis can restore patients’ “sense of self”
    In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices.
    Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches.
    Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical.
    Subscribe on all major podcast channels.
    56 min
  • VELYS, INHANCE and other reasons why DePuy Synthes sees Ortho opportunities; 2021’s top DTW episodes
    In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio.
    First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market.
    Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry.
    Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks.
    Subscribe to all these podcasts at most major podcast platforms.
    1 hr 1 min
  • Hear how Olympus plans to become an even bigger player in the medical device industry
    Happy New Year!
    In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years.
    COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry.
    Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker.
    Subscribe to catch future episodes on any major podcast player.
    1 hr 7 min
  • Exploring HeartMate, CardioMEMS and the rest of Abbott’s toolbox to help heart failure patients
    In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers.
    This podcast is sponsored by KNF.
    Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition.
    Dr. Kormos also shares the most gratifying part of his job.
    The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet.
    Happy New Year!!! We'll see you in 2022.
    LIKE! FOLLOW! SUBSCRIBE!
    1 hr 17 min
  • Recor, Medtronic share the state of Renal Denervation. Can Alva Health reduce the danger of strokes?
    In this episode we’ll explore potentially life-saving treatments for hypertension and stroke.
    First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program.
    Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney.
    We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system.
    Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer.
    Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic.
    Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension.
    You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.
    1 hr 12 min
  • Lobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growing
    In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day.
    In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging.
    Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product.
    In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific.
    We also talk about pie.
    1 hr 17 min
  • DT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two years
    This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
    This episode is sponsored by Medmarc.
    The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness.
    In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color.
    Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA.
    We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic.
    Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products.
    Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits.
    Subscribe to this podcast on all major podcast applications.
    1 hr 6 min
  • TAVR-Talks Part II! Where does Abbott see opportunity? How does Medtronic view competition?
    In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.
    50 min